Impact of Achievement of Complete Cytogenetic Response on Outcome in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents

We reviewed 216 consecutive patients with MDS and abnormal karyotype treated with hypomethylating agents between 4/04 and 10/12. Median follow-up was 17 months. Using IWG criteria, best responses were complete response (CR) in 79 patients (37%), partial response (PR) in 4 (2%), and hematologic impro...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am J Hematol
Hoofdauteurs: Jabbour, Elias, Strati, Paolo, Cabrero, Monica, O’Brien, Susan, Ravandi, Farhad, Bueso-Ramos, Carlos, Wei, Qiao, Hu, Jianhua, Aad, Simon Abi, Short, Nicholas J, Dinardo, Courtney, Daver, Naval, Kadia, Tapan, Wierda, William, Wei, Yue, Colla, Simona, Borthakur, Gautam, Cortes, Jorge, Estrov, Zeev, Kantarjian, Hagop, Garcia-Manero, Guillermo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5439522/
https://ncbi.nlm.nih.gov/pubmed/28076892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24650
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items